
The Hidden Costs of Inaccurate Migraine Disability Assessment
Migraine Disability (MD) is a significant burden on patients, healthcare systems, and the economy. Accurately assessing MD is crucial for effective treatment, prevention, and improving patient quality of life. Yet, many healthcare providers struggle to quantify MD, leading to suboptimal care and missed opportunities for intervention.

The Impact of Underestimated Migraine Disability
Underestimating MD can have severe consequences:
- Delayed Diagnosis of Comorbidities: Migraine is often associated with other conditions like depression, anxiety, and cardiovascular disease. Inaccurate MD assessment can delay the diagnosis of these comorbidities.
- Ineffective Treatment Plans: Underestimating the severity of MD can lead to suboptimal treatment plans, leaving patients with uncontrolled symptoms and reduced quality of life.
- Increased Healthcare Costs: Patients with undertreated migraines often require more frequent healthcare utilization, including emergency department visits and hospitalizations, driving up costs.

Kribado: Your Solution for Precise Migraine Disability Assessment
Kribado is a revolutionary patient screening tool designed to accurately assess Migraine Disability. By providing healthcare providers with real-time, data-driven insights, Kribado empowers them to:
- Tailor Treatment Plans: Develop personalized treatment strategies based on precise MD assessment.
- Identify High-Risk Patients: Proactively manage patients at higher risk of complications.
- Improve Patient Outcomes: Enhance patient quality of life through effective migraine management.
How Kribado Works
Kribado leverages advanced algorithms to analyze patient data and generate actionable insights. Our user-friendly platform enables healthcare providers to:
- Quickly assess patient migraine severity
- Identify potential comorbidities
- Track treatment effectiveness
- Optimize resource allocation

Trust Indigital Technologies for Your Migraine Management Solutions
Indigital Technologies is a trusted partner to the healthcare industry,
delivering innovative solutions that drive positive patient outcomes. With a proven track record of success and a deep understanding of the pharmaceutical landscape, we are committed to empowering healthcare providers with the tools they need to address complex challenges like migraine management.